Ljubljana Covid clinic suspends use of antibody treatment

Ljubljana – Slovenia’s main Covid treatment facility will suspend the use of monoclonal antibody treatment because it proved to be inefficient against Omicron, the head of the UKC Ljubljana Department of Infectious Diseases, Tatjana Lejko Zupanc, told the STA on Thursday. Patients with the Delta variant can still receive the treatment, she said, as patients are tested to determine which variant they have been infected with. But when only Omicron will circulate in the population Regeneron will no longer be used. So far, patients at risk of developing severe Covid…

For FREE further reading please JUST enter your email address

I allow to collect my email data for analytics and email campaign